Related Experiment Video
Updated: Feb 27, 2026
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Molecular mechanisms in cardiomyopathy
Keith Dadson1, Ludger Hauck1, Filio Billia2,3,4,5
1Toronto General Research Institute, Toronto, Ontario Canada, 100 College St., M5G 1L7.
Insights
Primary cardiomyopathies are heart muscle diseases with genetic or acquired causes. Research reveals genetic mutations and molecular mechanisms underlying conditions like hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM).
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Cardiomyopathies are diverse heart muscle diseases impacting cardiac function.
- Primary cardiomyopathies affect the myocardium, stemming from genetic or acquired factors.
- Examples include hypertrophic cardiomyopathy (HCM), arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D), mitochondrial cardiomyopathy, dilated cardiomyopathy (DCM), and restrictive cardiomyopathy (RCM).
Purpose of the Study:
- To review genetic and molecular abnormalities in primary cardiomyopathies.
- To discuss insights gained from genetic studies and basic science experimentation.
- To highlight advances in understanding disease mechanisms.
Main Methods:
- Review of modern genomics to identify common mutations.
- Analysis of in vitro and in vivo experimental data.
- Discussion of advances from traditional basic science research.
Main Results:
- Genomics has identified key mutations in cardiomyopathy populations.
- Molecular mechanisms elucidated include altered myosin heavy chain (MHC) binding in HCM and impaired calcium flux in DCM.
- Genetic testing aids in identifying inherited risk factors and disease manifestations.
Conclusions:
- Genetic mutations and molecular dysfunctions are central to primary cardiomyopathies.
- Integrated approaches using genomics and basic science provide crucial insights.
- Understanding these mechanisms is vital for diagnosing and potentially treating these heart conditions.
Abstract:
Cardiomyopathies represent a heterogeneous group of diseases that negatively affect heart function. Primary cardiomyopathies specifically target the myocardium, and may arise from genetic [hypertrophic cardiomyopathy (HCM), arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D), mitochondrial cardiomyopathy] or genetic and acquired [dilated cardiomyopathy (DCM), restrictive cardiomyopathy (RCM)] etiology. Modern genomics has identified mutations that are common in these populations, while in vitro and in vivo experimentation with these mutations have provided invaluable insight into the molecular mechanisms native to these diseases. For example, increased myosin heavy chain (MHC) binding and ATP utilization lead to the hypercontractile sarcomere in HCM, while abnormal protein-protein interaction and impaired Ca2+ flux underlie the relaxed sarcomere of DCM. Furthermore, expanded access to genetic testing has facilitated identification of potential risk factors that appear through inheritance and manifest sometimes only in the advanced stages of the disease. In this review, we discuss the genetic and molecular abnormalities unique to and shared between these primary cardiomyopathies and discuss some of the important advances made using more traditional basic science experimentation.
Related Concept Videos
01:25Cardiomyopathy I: Introduction and Classification
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
01:30Cardiomyopathy II: Dilated Cardiomyopathy
01:29Cardiomyopathy V: Interprofessional Care
01:17Pathophysiology of Heart Failure
01:21Myocarditis I: Introduction